Join PER® September 15th for the New York Advanced Practice Collaborative Meeting! Directed toward NP/PAs, this meeting blends presentations on cutting-edge information with panel discussions to enhance learning.

HIV-Positive Patients With Cancer Not Getting Equal Care, Study Finds

Friday, May 20, 2016
Adults with HIV and cancer are less likely to receive cancer treatment than patients who are solely suffering from cancer, according to a recent study published in the journal Cancer.

In addition to insurance and comorbidities, there are several factors that play a role in the treatment. They include demographics, psychosocial and economic challenges, access to clinical trials and physician concern.

Researchers observed the treatment for cancer of 10,265 HIV-infected people compared with more than two million without HIV. The study focused on the 10 most common cancers among HIV patients: cancers of the head and neck (oral cavity, pharynx, and larynx), upper gastrointestinal tract (pancreas, stomach, and esophagus), colorectal, anal, lung, female breast, cervical, and prostate; Hodgkin lymphoma; and diffuse large B-cell lymphoma (DLBCL).

Demographics differed between the HIV-infected group and the HIV-uninfected group. HIV-infected patients were often younger, male, non-Hispanic black and Hispanic. Most HIV-infected patients had Medicaid, Medicare or no insurance at all as opposed to private insurance, which was held by a majority of the HIV-uninfected group. Additionally, more HIV-infected patients were diagnosed with stage 4 cancer than HIV-uninfected patients (37.2 vs 18.9%). HIV-uninfected patients, on the other hand, were often diagnosed with stage 1 or 2 cancers (57.2 vs 33.2%).

Two of the biggest finds were that black patients and with Medicaid, Medicare, or no insurance were more likely to be untreated for cancer, regardless of tumor type; and that older age was associated with a lack of treatment for both lymphomas and solid tumors.

The treatment of the upper gastrointestinal tract, colorectal, lung, breast, prostate, Hodgkin lymphoma, and DLBCL cancers was significantly less for HIV-infected patients with private insurance compared with HIV-uninfected also privately insured. The only cancer treatment where rates did not differ significantly was for HIV-infected and HIV-uninfected patients with anal cancer.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.